Alan Jay Weisberg - 07 Oct 2022 Form 4 Insider Report for Progressive Care Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Nov 2022, 17:24:05 UTC
Prior SEC filing
06 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alan Jay Weisberg

Key filing fact

Alan Jay Weisberg filed Form 4 for Progressive Care Inc. on 04 Nov 2022.

Key facts

  • This page summarizes Alan Jay Weisberg's Form 4 filing for Progressive Care Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2022, 17:24.

Change

  • Previous filing in this sequence was filed on 06 Jan 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXMD transaction

Common Stock

Award

Transaction value
$0
Shares
+15,000,000
Change %
+145%
Price
$0.000000
Shares after
25,356,201
Date
07 Oct 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

RSUs immediately vested and were accelerated pursuant to approval by the Compensation Committee and the Board of Directors of the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .